GNPX (STOCKS)
Genprex, Inc. Common Stock
$1.219100
+0.069100 (+6.01%)
Prev close: $1.150000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Ryan M. Confer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $11.17M
- Employees
- 15
- P/E (TTM)
- -0.04
- P/B (TTM)
- 0.48
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Costs And Expenses | $15.52M |
| Research and Development | $9.43M |
| Operating Income/Loss | -$15.52M |
| Income/Loss From Continuing Operations After Tax | -$16.23M |
| Income/Loss From Continuing Operations Before Tax | -$15.52M |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$16.23M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$16.23M |
| Net Income/Loss Available To Common Stockholders, Basic | -$16.23M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$17.40 |
| Basic Average Shares | 932,730 |
| Assets | $10.16M |
| Current Assets | $8.36M |
| Noncurrent Assets | $1.80M |
| Fixed Assets | $0.00 |
| Liabilities | $2.20M |
| Current Liabilities | $2.17M |
| Noncurrent Liabilities | $22.50K |
| Equity | $7.96M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $7.96M |
| Liabilities And Equity | $10.16M |
| Net Cash Flow From Operating Activities | -$15.31M |
| Net Cash Flow From Operating Activities, Continuing | -$15.31M |
| Net Cash Flow From Investing Activities | -$6.23M |
| Net Cash Flow From Investing Activities, Continuing | -$6.23M |
| Net Cash Flow From Financing Activities | $21.54M |
| Net Cash Flow From Financing Activities, Continuing | $21.54M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$16.23M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$16.23M |
| Other Comprehensive Income/Loss | $0.00 |